Stock ILM MIM MONDO IGEL MEDIA AG
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

MIM MONDO IGEL MEDIA AG Share Price Xetra

Equities

ILM

DE000A0BVUP8

Pharmaceuticals

End-of-day quote Xetra
Other stock markets
- EUR - Intraday chart for MIM MONDO IGEL MEDIA AG
05-07 Medios AG Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-07 Transcript : Medios AG, Q1 2024 Earnings Call, May 07, 2024
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 2B 2.17B 170B Sales 2025 * 2.04B 2.22B 173B Capitalization 343M 372M 29.15B
Net income 2024 * 27M 29.34M 2.3B Net income 2025 * 31M 33.68M 2.64B EV / Sales 2024 * 0.24 x
Net Debt 2024 * 144M 156M 12.25B Net cash position 2025 * 17.31M 18.81M 1.47B EV / Sales 2025 * 0.16 x
P/E ratio 2024 *
12.9 x
P/E ratio 2025 *
11.4 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99%
More Fundamentals * Assessed data

Latest news about MIM MONDO IGEL MEDIA AG

Medios AG Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transcript : Medios AG, Q1 2024 Earnings Call, May 07, 2024
Medios AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Medios AG Provides Earnings Guidance for the Year 2024 CI
Transcript : Medios AG, Ceban B.V. - M&A Call
Medios AG agreed to acquire Ceban B.V. from Bencis Capital Partners B.V. for ? 259 million. CI
Medios AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Medios AG, Q3 2023 Earnings Call, Nov 14, 2023
Medios AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Transcript : Medios AG, H1 2023 Earnings Call, Aug 14, 2023
Medios to Sell Kölsche Blister Unit Amid Plan to Centralize Blister Business in Germany MT
Medios AG Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Transcript : Medios AG, Q1 2023 Earnings Call, May 11, 2023
Medios AG Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Medios AG Reports Earnings Results for the Full Year Ended December 31, 2022 CI
More news

Latest transcript on MIM MONDO IGEL MEDIA AG

Logo MIM MONDO IGEL MEDIA AG
Medios AG, Q1 2024 Earnings Call, May 07, 2024
More transcripts

Analyst Recommendations on MIM MONDO IGEL MEDIA AG

Berenberg EU Opportunities Conference FA
Berenberg European Conference FA
MEDIOS : Buy rating from Deutsche Bank ZD
MEDIOS : Warburg Research reiterates its Buy rating ZD
MEDIOS : Jefferies reiterates its Buy rating ZD
More recommendations

Press releases MIM MONDO IGEL MEDIA AG

Medios : 240507 Presentation Reporting Q1 24 final PU
Medios : Unternehmenspräsentation PU
Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance EQ
Medios AG: Constantijn van Rietschoten appointed Executive Board member for International Markets EQ
Medios : 240507 Presentation Reporting Q1 24 final PU
More press releases

News in other languages on MIM MONDO IGEL MEDIA AG

Medios AG verzeichnet im ersten Quartal 2024 weiteres Umsatzwachstum und bestätigt Gesamtjahresprognose
Medios AG verzeichnet im ersten Quartal 2024 weiteres Umsatzwachstum und bestätigt Gesamtjahresprognose
TAGESVORSCHAU/Dienstag, 7. Mai
Medios : 240507 Medios AG Pressemitteilung Q1 2024
TAGESVORSCHAU/Dienstag, 7. Mai (vorläufige Fassung)
More news

Managers and Directors - MIM MONDO IGEL MEDIA AG

Managers TitleAgeSince
Matthias A. Gärtner CEO
 Chief Executive Officer 56 05/11/14
Falk Neukirch DFI
 Director of Finance/CFO 53 30/09/21
Mi Young Miehler COO
 Chief Operating Officer 55 30/06/17
Members of the board TitleAgeSince
Yann Samson CHM
 Chairman 51 06/11/14
Klaus Buß BRD
 Director/Board Member 62 13/09/16
Joachim Messner BRD
 Director/Board Member 63 13/09/16
More insiders

Company Profile

Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.
Sector
Pharmaceuticals
Calendar
05/06/2024 - Warburg Highlights Conference
More about the company

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+43.76% 750B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+34.11% 606B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.26% 356B
MERCK & CO., INC. Stock Merck & Co., Inc.
+18.95% 326B
ABBVIE INC. Stock AbbVie Inc.
+6.61% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.08% 246B
ROCHE HOLDING AG Stock Roche Holding AG
-3.44% 213B
NOVARTIS AG Stock Novartis AG
+11.35% 213B
PFIZER, INC. Stock Pfizer, Inc.
+2.21% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ILM1 Stock
  4. ILM Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW